Company news
3d Medicines, Inc. (HKEX:1244) news
3d Medicines, Inc. news releases on 6ix. Latest, Oct 2, 2026: CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE
Press releases & updates
CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE
October 2, 2026
Interim Report 2026
September 30, 2026
3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA
February 9, 2026
3D Medicines Inc Says Zhang Jing Resigns As CFO
January 12, 2026
3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted
January 9, 2026
3D Medicines Says Envafoimab Granted Orphan Drug Designation
December 22, 2025